Neuroprotective Effects of Estrogen Following Neural Injury

Estrogen Effects on Traumatic Brain Injury: Mechanisms of Neuroprotection and Repair

Volumn , Issue , 2015, Pages 91-111

  Petrone, Ashley B ^a,b,d   Rudy, Carolyn C ^a   Barr, Taura L ^b,d   Simpkins, James W ^c,d   Reed, Miranda N ^a,d  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b WEST VIRGINIA UNIVERSITY SCHOOL OF NURSING   (United States)

^c WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Estrogen; Immune system; Stroke; Traumatic brain injury

Indexed keywords

EID: 84934987945     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-801479-0.00007-3     Document Type: Chapter

References (96)

1. Alkayed N.J., Goto S., Sugo N., Joh H.D., Klaus J., Crain B.J., et al. Estrogen and Bcl-2: gene induction and effect of transgene in experimental stroke. J. Neurosci. 2001, 21(19):7543-7550.
2. Alvarez-de-la-Rosa M., Silva I., Nilsen J., Pérez M.M., García-Segura L.M., Avila J., et al. Estradiol prevents neural tau hyperphosphorylation characteristic of Alzheimer's disease. Ann. N. Y. Acad. Sci. 2005, 224:210-224.
3. Alzheimer's Association Alzheimer's disease facts and figures. Alzheimers Dement. 2012, 8(2):131-168.
4. Anderson G.L., Limacher M., Assaf A.R., Bassford T., Beresford S.A.A., Black H., et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004, 291(14):1701-1712.
5. Appelros P., Stegmayr B., Terént A. Sex differences in stroke epidemiology: a systematic review. Stroke 2009, 40(4):1082-1090.
6. Asl S.Z., Khaksari M., Khachki A.S., Shahrokhi N., Nourizade S. Contribution of estrogen receptors alpha and beta in the brain response to traumatic brain injury. J. Neurosurg. 2013, 119(2):353-361.
7. Barnham K.J., Masters C.L., Bush A.I. Neurodegenerative diseases and oxidative stress. Nat. Rev. Drug Discov. 2004, 3(3):205-214.
8. Behl C., Skutella T., Lezoualc'h F., Post A., Widmann M., Newton C.J., et al. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol. Pharmacol. 1997, 51(4):535-541.
9. Brailoiu E., Dun S.L., Brailoiu G.C., Mizuo K., Sklar L.A., Oprea T.I., et al. Distribution and characterization of estrogen receptor G protein-coupled receptor 30 in the rat central nervous system. J. Endocrinol. 2007, 193(2):311-321.
10. Bramlett H.M., Dietrich W.D. Neuropathological protection after traumatic brain injury in intact female rats versus males or ovariectomized females. J. Neurotrauma 2001, 18(9):891-900.
11. Brown R.C., Lockwood A.H., Sonawane B.R. Neurodegenerative diseases: an overview of environmental risk factors. Environ. Health Perspect. 2005, 113(9):1250-1256.
12. Carroll J.C., Rosario E.R., Chang L., Stanczyk F.Z., Oddo S., LaFerla F.M., et al. Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J. Neurosci. 2007, 27(48):13357-13365.
13. Chen S.-H., Chang C.-Y., Chang H.-K., Chen W.-C., Lin M.-T., Wang J.-J., et al. Premarin stimulates estrogen receptor-alpha to protect against traumatic brain injury in male rats. Crit. Care Med. 2009, 37(12):3097-3106.
14. Choi Y.C., Lee J.H., Hong K.W., Lee K.S. 17 Beta-estradiol prevents focal cerebral ischemic damages via activation of Akt and CREB in association with reduced PTEN phosphorylation in rats. Fundam. Clin. Pharmacol. 2004, 18(5):547-557.
15. Coker L.H., Hogan P.E., Bryan N.R., Kuller L.H., Margolis K.L., Bettermann K., et al. Postmenopausal hormone therapy and subclinical cerebrovascular disease: the WHIMS-MRI Study. Neurology 2009, 72(2):125-134.
16. Coronado V.G., Xu L., Basavaraju S.V., McGuire L.C., Wald M.M., Faul M.D., et al. Surveillance for traumatic brain injury-related deaths in the United States. Surveill. Summ. 2011, 60(SS05):1-32.
17. Coronado V.G., McGuire L.C., Sarmiento K., Bell J., Lionbarger M.R., Jones C.D., et al. Trends in traumatic brain injury in the U.S. and the public health response: 1995-2009. J. Safety Res. 2012, 43(4):299-307.
18. Crosby K.M., Connell B.J., Saleh T.M. Estrogen limits ischemic cell death by modulating caspase-12-mediated apoptotic pathways following middle cerebral artery occlusion. Neuroscience 2007, 146(4):1524-1535.
19. Day N.L., Floyd C.L., D'Alessandro T.L., Hubbard W.J., Chaudry I.H. 17β-estradiol confers protection after traumatic brain injury in the rat and involves activation of G protein-coupled estrogen receptor 1. J. Neurotrauma 2013, 30(17):1531-1541.
20. De Leciñana M.A., Egido J.A., Fernández C., Martínez-Vila E., Santos S., Morales A., et al. PIVE Study Investigators of the Stroke Project of the Spanish Cerebrovascular Diseases Study Group. Risk of ischemic stroke and lifetime estrogen exposure. Neurology 2007, 68(1):33-38.
21. Dubal D.B., Wise P.M. Neuroprotective effects of estradiol in middle-aged female rats. Endocrinology 2001, 142(1):43-48.
22. Dubal D.B., Kashon M.L., Pettigrew L.C., Ren J.M., Finklestein S.P., Rau S.W., et al. Estradiol protects against ischemic injury. J. Cereb. Blood Flow Metab. 1998, 18(11):1253-1258.
23. Dubal D.B., Shughrue P.J., Wilson M.E., Merchenthaler I., Wise P.M. Estradiol modulates bcl-2 in cerebral ischemia: a potential role for estrogen receptors. J. Neurosci. 1999, 19(15):6385-6393.
24. Dubey R.K., Imthurn B., Barton M., Jackson E.K. Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen. Cardiovasc. Res. 2005, 66(2):295-306.
25. Filardo E.J., Quinn J.A., Bland K.I., Frackelton A.R. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol. Endocrinol. 2000, 14(10):1649-1660.
26. Fitzpatrick J.L., Mize A.L., Wade C.B., Harris J.A., Shapiro R.A., Dorsa D.M. Estrogen-mediated neuroprotection against beta-amyloid toxicity requires expression of estrogen receptor alpha or beta and activation of the MAPK pathway. J. Neurochem. 2002, 82(3):674-682.
27. Garcia-Segura L.M., Wozniak A., Azcoitia I., Rodriguez J.R., Hutchison R.E., Hutchison J.B. Aromatase expression by astrocytes after brain injury: implications for local estrogen formation in brain repair. Neuroscience 1999, 89(2):567-578.
28. Gatson J.W., Maass D.L., Simpkins J.W., Idris A.H., Minei J.P., Wigginton J.G. Estrogen treatment following severe burn injury reduces brain inflammation and apoptotic signaling. J. Neuroinflammation 2009, 6:30.
29. Gatson J.W., Simpkins J.W., Yi K.D., Idris A.H., Minei J.P., Wigginton J.G. Aromatase is increased in astrocytes in the presence of elevated pressure. Endocrinology 2011, 152(1):207-213.
30. Gatson J.W., Liu M.-M., Abdelfattah K., Wigginton J.G., Smith S., Wolf S., et al. Estrone is neuroprotective in rats after traumatic brain injury. J. Neurotrauma 2012, 29(12):2209-2219.
31. Gibson C.L., Gray L.J., Murphy S.P., Bath P.M.W. Estrogens and experimental ischemic stroke: a systematic review. J. Cereb. Blood Flow Metab. 2006, 26(9):1103-1113.
32. Go A.S., Mozaffarian D., Roger V.L., Benjamin E.J., Berry J.D., Borden W.B., et al. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013, 127(1):e6-e245.
33. Goodenough S., Schleusner D., Pietrzik C., Skutella T., Behl C. Glycogen synthase kinase 3β links neuroprotection by 17β-estradiol to key Alzheimer processes. Neuroscience 2005, 132(3):581-589.
34. Green P.S., Gordon K., Simpkins J.W. Phenolic A ring requirement for the neuroprotective effects of steroids. J. Steroid Biochem. Mol. Biol. 1997, 63(4-6):229-235.
35. Grodstein F., Manson J.E., Stampfer M.J., Rexrode K. Postmenopausal hormone therapy and stroke: role of time since menopause and age at initiation of hormone therapy. Arch. Intern. Med. 2008, 168(8):861-866.
36. Gustafsson J.A. What pharmacologists can learn from recent advances in estrogen signalling. Trends Pharmacol. Sci. 2003, 24(9):479-485.
37. Hall J.M., Couse J.F., Korach K.S. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J. Biol. Chem. 2001, 276(40):36869-36872.
38. Harukuni I., Hurn P.D., Crain B.J. Deleterious effect of beta-estradiol in a rat model of transient forebrain ischemia. Brain Res. 2001, 900(1):137-142.
39. Hazell G.G.J., Yao S.T., Roper J.A., Prossnitz E.R., O'Carroll A.-M., Lolait S.J. Localisation of GPR30, a novel G protein-coupled oestrogen receptor, suggests multiple functions in rodent brain and peripheral tissues. J. Endocrinol. 2009, 202(2):223-236.
40. Hebert L.E., Weuve J., Scherr P.A., Evans D.A. Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology 2013, 80(19):1778-1783.
41. Heldring N., Pike A., Andersson S., Matthews J., Cheng G., Hartman J., et al. Estrogen receptors: how do they signal and what are their targets. Physiol. Rev. 2007, 87(3):905-931.
42. Huber B.R., Meabon J.S., Martin T.J., Mourad P.D., Bennett R., Kraemer B.C., et al. Blast exposure causes early and persistent aberrant phospho- and cleaved-tau expression in a murine model of mild blast-induced traumatic brain injury. J. Alzheimers Dis. 2013, 37:309-323.
43. Hunter C.L., Bimonte-Nelson H.A., Nelson M., Eckman C.B., Granholm A.-C. Behavioral and neurobiological markers of Alzheimer's disease in Ts65Dn mice: effects of estrogen. Neurobiol. Aging 2004, 25(7):873-884.
44. Iadecola C., Anrather J. The immunology of stroke: from mechanisms to translation. Nat. Med. 2011, 17(7):796-808.
45. Ishunina T.A., Fischer D.F., Swaab D.F. Estrogen receptor alpha and its splice variants in the hippocampus in aging and Alzheimer's disease. Neurobiol. Aging 2007, 28(11):1670-1681.
46. Jia J., Guan D., Zhu W., Alkayed N.J., Wang M.M., Hua Z., et al. Estrogen inhibits Fas-mediated apoptosis in experimental stroke. Exp. Neurol. 2009, 215(1):48-52.
47. Kamel H., Iadecola C. Brain-immune interactions and ischemic stroke: clinical implications. Arch. Neurol. 2012, 69(5):576-581.
48. Koellhoffer E.C., McCullough L.D. The effects of estrogen in ischemic stroke. Transl. Stroke Res. 2013, 4(4):390-401.
49. Lakhan S.E., Kirchgessner A., Hofer M. Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J. Transl. Med. 2009, 7:97.
50. Lapanantasin S., Chongthammakun S., Floyd C.L., Berman R.F. Effects of 17β-estradiol on intracellular calcium changes and neuronal survival after mechanical strain injury in neuronal-glial cultures. Synapse 2006, 410(May):406-410.
51. Leon R.L., Li X., Huber J.D., Rosen C.L. Worsened outcome from middle cerebral artery occlusion in aged rats receiving 17β-estradiol. Endocrinology 2012, 153(7):3386-3393.
52. Levin-Allerhand J.A., Lominska C.E., Wang J., Smith J.D. 17α-estradiol and 17β-estradiol treatments are effective in lowering cerebral amyloid-β levels in AβPPSWE transgenic mice. J. Alzheimers Dis. 2002, 4:449-457.
53. Li Y., Wang S., Xia Y., Wang J., Pan W., Shi Y., et al. Neuroprotective effect of estrogen after chronic spinal cord injury in ovariectomized rats. Neural Regen. Res. 2007, 2(8):471-474.
54. Liang K., Yang L., Yin C., Xiao Z., Zhang J., Liu Y., et al. Estrogen stimulates degradation of beta-amyloid peptide by up-regulating neprilysin. J. Biol. Chem. 2010, 285(2):935-942.
55. Liu X.-A., Zhu L.-Q., Zhang Q., Shi H.-R., Wang S.-H., Wang Q., et al. Estradiol attenuates tau hyperphosphorylation induced by upregulation of protein kinase-A. Neurochem. Res. 2008, 33(9):1811-1820.
56. Lobo R.A. Where are we 10 years after the Women's Health Initiative?. J. Clin. Endocrinol. Metab. 2013, 98(5):1771-1780.
57. López Rodríguez A.B., Mateos Vicente B., Romero-Zerbo S.Y., Rodriguez-Rodriguez N., Bellini M.J., Rodriguez de Fonseca F., et al. Estradiol decreases cortical reactive astrogliosis after brain injury by a mechanism involving cannabinoid receptors. Cereb. Cortex 2011, 21(9):2046-2055.
58. Manthey D., Heck S., Engert S., Behl C. Estrogen induces a rapid secretion of amyloid beta precursor protein via the mitogen-activated protein kinase pathway. Eur. J. Biochem. 2001, 268(15):4285-4291.
59. Marin R., Guerra B., Morales A., Díaz M., Alonso R. An oestrogen membrane receptor participates in estradiol actions for the prevention of amyloid-β peptide1-40-induced toxicity in septal-derived cholinergic SN56 cells. J. Neurochem. 2003, 85(5):1180-1189.
60. Mattson M.P. Apoptosis in neurodegenerative disorders. Nat. Rev. Mol. Cell Biol. 2000, 1(2):120-129.
61. Moore D.W., Ashman T.A., Cantor J.B., Krinick R.J., Spielman L.A. Does gender influence cognitive outcome after traumatic brain injury?. Neuropsychol. Rehabil. 2010, 20(3):340-354.
62. Nadkarni S., McArthur S. Oestrogen and immunomodulation: new mechanisms that impact on peripheral and central immunity. Curr. Opin. Pharmacol. 2013, 13(4):576-581.
63. Nilsen J., Chen S., Irwin R.W., Iwamoto S., Brinton R.D. Estrogen protects neuronal cells from amyloid beta-induced apoptosis via regulation of mitochondrial proteins and function. BMC Neurosci. 2006, 7(74):1-14.
64. Nortje J., Menon D.K. Traumatic brain injury: physiology, mechanisms, and outcome. Curr. Opin. Neurol. 2004, 17(6):711-718.
65. Paganini-Hill A., Henderson V.W. Estrogen deficiency and risk of Alzheimer's disease in women. Am. J. Epidemiol. 1994, 140(3):256-261.
66. Perez E., Liu R., Yang S.-H., Cai Z.Y., Covey D.F., Simpkins J.W. Neuroprotective effects of an estratriene analog are estrogen receptor independent in vitro and in vivo. Brain Res. 2005, 1038(2):216-222.
67. Petanceska S.S., Nagy V., Frail D., Gandy S. Ovariectomy and 17β-estradiol modulate the levels of Alzheimer's amyloid β peptides in brain. Exp. Gerontol. 2000, 35:1317-1325.
68. Piau A., Nourhashémi F., Hein C., Caillaud C., Vellas B. Progress in the development of new drugs in Alzheimer's disease. J. Nutr. Health Aging 2010, 15(1):45-57.
69. Prokai L., Prokai-Tatrai K., Perjesi P., Zharikova A.D., Perez E.J., Liu R., et al. Quinol-based cyclic antioxidant mechanism in estrogen neuroprotection. Proc. Natl. Acad. Sci. USA 2003, 100(20):11741-11746.
70. Rao A.K., Dietrich A.K., Ziegler Y.S., Nardulli A.M. 17β-Estradiol-mediated increase in Cu/Zn superoxide dismutase expression in the brain: a mechanism to protect neurons from ischemia. J. Steroid Biochem. Mol. Biol. 2011, 127(3-5):382-389.
71. Rau S.W., Dubal D.B., Böttner M., Wise P.M. Estradiol differentially regulates c-Fos after focal cerebral ischemia. J. Neurosci. 2003, 23(33):10487-10494.
72. Raval A.P., Saul I., Dave K.R., DeFazio R.A., Perez-Pinzon M.A., Bramlett H. Pretreatment with a single estradiol-17β bolus activates cyclic-AMP response element binding protein and protects CA1 neurons against global cerebral ischemia. Neuroscience 2009, 160(2):307-318.
73. Richardson T.E., Yang S.-H., Wen Y., Simpkins J.W. Estrogen protection in Friedreich's ataxia skin fibroblasts. Endocrinology 2011, 152(7):2742-2749.
74. Ritzel R.M., Capozzi L.A., McCullough L.D. Sex, stroke, and inflammation: the potential for estrogen-mediated immunoprotection in stroke. Horm. Behav. 2013, 63(2):238-253.
75. Rusa R., Alkayed N.J., Crain B.J., Traystman R.J., Kimes A.S., London E.D., et al. 17β-estradiol reduces stroke injury in estrogen-deficient female animals. Stroke 1999, 30(8):1665-1670.
76. Shughrue P.J., Merchenthaler I. Estrogen prevents the loss of CA1 hippocampal neurons in gerbils after ischemic injury. Neuroscience 2003, 116(3):851-861.
77. Simpkins J.W., Rajakumar G., Zhang Y.Q., Simpkins C.E., Greenwald D., Yu C.J., et al. Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. J. Neurosurg. 1997, 87(5):724-730.
78. Simpkins J.W., Perez E., Wang X., Yang S., Wen Y., Singh M. The potential for estrogens in preventing Alzheimer's disease and vascular dementia. Ther. Adv. Neurol. Disord. 2009, 2(1):31-49.
79. Singer C.A., Rogers K.L., Dorsa D.M. Modulation of Bcl-2 expression: a potential component of estrogen protection in NT2 neurons. Neuroreport 1998, 9(11):2565-2568.
80. Singer C.A., Figueroa-Masot X.A., Batchelor R.H., Dorsa D.M. The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J. Neurosci. 1999, 19(7):2455-2463.
81. Soustiel J.F., Palzur E., Nevo O., Thaler I., Vlodavsky E. Neuroprotective anti-apoptosis effect of estrogens in traumatic brain injury. J. Neurotrauma 2005, 22(3):345-352.
82. Stoltzner S.E., Berchtold N.C., Cotman C.W., Pike C.J. Estrogen regulates bcl-x expression in rat hippocampus. Neuroreport 2001, 12(13):2797-2800.
83. Sung J.-H., Cho E.-H., Min W., Kim M.-J., Kim M.-O., Jung E.-J., et al. Identification of proteins regulated by estradiol in focal cerebral ischemic injury-a proteomics approach. Neurosci. Lett. 2010, 477(2):66-71.
84. Tamatani M., Ogawa S., Nuñez G., Tohyama M. Growth factors prevent changes in Bcl-2 and Bax expression and neuronal apoptosis induced by nitric oxide. Cell Death Differ. 1998, 5(10):911-919.
85. Wang R., Zhang Q.-G., Han D., Xu J., Lü Q., Zhang G.-Y. Inhibition of MLK3-MKK4/7-JNK1/2 pathway by Akt1 in exogenous estrogen-induced neuroprotection against transient global cerebral ischemia by a non-genomic mechanism in male rats. J. Neurochem. 2006, 99(6):1543-1554.
86. Wen Y., Yang S., Liu R., Brun-Zinkernagel A.M., Koulen P., Simpkins J.W. Transient cerebral ischemia induces aberrant neuronal cell cycle re-entry and Alzheimer's disease-like tauopathy in female rats. J. Biol. Chem. 2004, 279(21):22684-22692.
87. Xu H., Gouras G.K., Greenfield J.P., Vincent B., Naslund J., Mazzarelli L., et al. Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides. Nat. Med. 1998, 4(4):447-451.
88. Xu H., Wang R., Zhang Y.-W., Zhang X. Estrogen, beta-amyloid metabolism/trafficking, and Alzheimer's disease. Ann. N. Y. Acad. Sci. 2006, 1089:324-342.
89. Yang S.H., Shi J., Day A.L., Simpkins J.W. Estradiol exerts neuroprotective effects when administered after ischemic insult. Stroke 2000, 31(3):745-749. discussion 749-750.
90. Yeung J.H.H., Mikocka-Walus A.A., Cameron P.A., Poon Q.S., Ho H.F., Chang A., et al. Protection from traumatic brain injury in hormonally active women vs. men of a similar age. Arch. Surg. 2011, 146(4):436-442.
91. Zhang Q.-G., Wang R., Khan M., Mahesh V., Brann D.W. Role of Dickkopf-1, an antagonist of the Wnt/beta-catenin signaling pathway, in estrogen-induced neuroprotection and attenuation of tau phosphorylation. J. Neurosci. 2008, 28(34):8430-8441.
92. Zhang Y.Q., Shi J., Rajakumar G., Day A.L., Simpkins J.W. Effects of gender and estradiol treatment on focal brain ischemia. Brain Res. 1998, 784(1-2):321-324.
93. Zhang Z., Simpkins J.W. Okadaic acid induces tau phosphorylation in SH-SY5Y cells in an estrogen-preventable manner. Brain Res. 2010, 1345:176-181.
94. Zhao L., Yao J., Mao Z., Chen S., Wang Y., Brinton R.D. 17β-Estradiol regulates insulin-degrading enzyme expression via an ERβ/PI3-K pathway in hippocampus: relevance to Alzheimer's prevention. Neurobiol. Aging 2011, 32(11):1949-1963.
95. Zheng H., Xu H., Uljon S.N., Gross R., Hardy K., Gaynor J., et al. Modulation of A(beta) peptides by estrogen in mouse models. J. Neurochem. 2002, 80(1):191-196.
96. Zlotnik A., Leibowitz A., Gurevich B., Ohayon S., Boyko M., Klein M., et al. Effect of estrogens on blood glutamate levels in relation to neurological outcome after TBI in male rats. Intensive Care Med. 2012, 38(1):137-144.